AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
SPANISH ACUTE LYMPHOBLASTIC-LEUKEMIA TRIALS
Authors: ORTEGA JJ
Citation: Jj. Ortega, SPANISH ACUTE LYMPHOBLASTIC-LEUKEMIA TRIALS, International journal of pediatric hematology/oncology, 5(2-4), 1998, pp. 163-176
UMBILICAL-CORD BLOOD AS A GOOD ALTERNATIVE TO BONE-MARROW FOR ALLOGENEIC CELL TRANSPLANTATION IN CHILDREN WITH HEMOBLASTOSIS
Authors: DEHEREDIA CD ORTEGA JJ OLIVE T COLL MT TORRABADELLA M MASSUET L
Citation: Cd. Deheredia et al., UMBILICAL-CORD BLOOD AS A GOOD ALTERNATIVE TO BONE-MARROW FOR ALLOGENEIC CELL TRANSPLANTATION IN CHILDREN WITH HEMOBLASTOSIS, Bone marrow transplantation, 22, 1998, pp. 80-82
MEGATHERAPY IN CHILDREN WITH HIGH-RISK EWINGS-SARCOMA IN FIRST COMPLETE REMISSION
Authors: MADERO L MUNOZ A DETOLEDO JS DIAZ MA MALDONADO MS ORTEGA JJ RAMIREZ M OTHEO E BENITO A SALAS S
Citation: L. Madero et al., MEGATHERAPY IN CHILDREN WITH HIGH-RISK EWINGS-SARCOMA IN FIRST COMPLETE REMISSION, Bone marrow transplantation, 21(8), 1998, pp. 795-799
PROCEEDINGS OF THE FIRST MEETING OF THE WORKING PARTY ON PEDIATRIC DISEASES OF THE EBMT - BARCELONA, MAY 7-9, 1998 - FOREWORD
Authors: ORTEGA JJ
Citation: Jj. Ortega, PROCEEDINGS OF THE FIRST MEETING OF THE WORKING PARTY ON PEDIATRIC DISEASES OF THE EBMT - BARCELONA, MAY 7-9, 1998 - FOREWORD, Bone marrow transplantation, 21, 1998, pp. 1-1
UMBILICAL-CORD BLOOD (UCB) IS A GOOD ALTERNATIVE TO BONE-MARROW FOR ALLOGENEIC HEMATOPOIETIC-CELLS TRANSPLANTATION IN CHILDREN
Authors: ORTEGA JJ OLIVE T DEHEREDIA CD TORRABADELLA M MASSUET L
Citation: Jj. Ortega et al., UMBILICAL-CORD BLOOD (UCB) IS A GOOD ALTERNATIVE TO BONE-MARROW FOR ALLOGENEIC HEMATOPOIETIC-CELLS TRANSPLANTATION IN CHILDREN, Bone marrow transplantation, 21, 1998, pp. 10-10
HEMATOPOIETIC PROGENITOR-CELL TRANSPLANT IN ACUTE LEUKEMIAS IN CHILDREN - INDICATIONS, RESULTS AND CONTROVERSIES
Authors: ORTEGA JJ OLIVE T
Citation: Jj. Ortega et T. Olive, HEMATOPOIETIC PROGENITOR-CELL TRANSPLANT IN ACUTE LEUKEMIAS IN CHILDREN - INDICATIONS, RESULTS AND CONTROVERSIES, Bone marrow transplantation, 21, 1998, pp. 11-16
ALLOGENEIC STEM-CELL TRANSPLANTATION FOR FANCONI-ANEMIA
Authors: GUARDIOLA P SOCIE G PASQUINI R DOKAL I ORTEGA JJ VANWEELSIPMAN M MARSH J LOCATELLI F SOUILLET G CAHN JY LJUNGMAN P MINIERO R SHAW J VERMYLEN C ARCHIMBAUD E BEKASSY AN KRIVAN G DIBARTOLOMEO P BACIGALUPO A GLUCKMAN E
Citation: P. Guardiola et al., ALLOGENEIC STEM-CELL TRANSPLANTATION FOR FANCONI-ANEMIA, Bone marrow transplantation, 21, 1998, pp. 24-27
QUALITY-OF-LIFE IN YOUNG-ADULTS HAVING RECEIVED A BMT DURING CHILDHOOD - A GETMON STUDY
Authors: BADELL I IGUAL L GOMEZ P BUREO E ORTEGA JJ CUBELLS J MUNOZ A MARTINEZ A MADERO L VERDEGUER A TORRES A RICHARD C OLIVE T DANIEL M BAYES R
Citation: I. Badell et al., QUALITY-OF-LIFE IN YOUNG-ADULTS HAVING RECEIVED A BMT DURING CHILDHOOD - A GETMON STUDY, Bone marrow transplantation, 21, 1998, pp. 68-71
UMBILICAL-CORD BLOOD (UCB) AS A GOOD ALTERNATIVE TO BONE-MARROW FOR ALLOGENEIC HEMATOPOIETIC-CELLS TRANSPLANTATION IN CHILDREN
Authors: ORTEGA JJ OLIVE T DEHEREDIA CD TORRABADELLA M MASSUET L
Citation: Jj. Ortega et al., UMBILICAL-CORD BLOOD (UCB) AS A GOOD ALTERNATIVE TO BONE-MARROW FOR ALLOGENEIC HEMATOPOIETIC-CELLS TRANSPLANTATION IN CHILDREN, Bone marrow transplantation, 21, 1998, pp. 80-80
CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT) - A SURVEY OF THE INFECTIOUS-DISEASES WORKING PARTY OF EBMT
Authors: LINK H ARSENIEV L LJUNGMAN P ALESSANDRINO EP AMADORI S BANDINI G BEGUIN Y BRINCH L BRUNET S CHOPRA R CORDONNIER C DEWITTE T FAUSER A FERRANT A GARCIACONDE J JULIUSSON G KUBEL M MANNA AT MARTINEZRUBIO AM MUNDHENK P ORDEMANN R ORTEGA JJ POTTER M PRENTICE HG RAIMONDI R REMEZ K REUSSER P ROVIRA M RUSSELL J SELLESLAG D UDERZO C ZAUCHA JM
Citation: H. Link et al., CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT) - A SURVEY OF THE INFECTIOUS-DISEASES WORKING PARTY OF EBMT, Bone marrow transplantation, 21, 1998, pp. 479-479
INCIDENCE OF VENO-OCLUSIVE DISEASE (VOD) OF THE LIVER IN CHILDREN
Authors: OLIVE T BADELL Y VERDEGUER A GOMEZ P ORTEGA JJ
Citation: T. Olive et al., INCIDENCE OF VENO-OCLUSIVE DISEASE (VOD) OF THE LIVER IN CHILDREN, Bone marrow transplantation, 21, 1998, pp. 760-760
QUALITY-OF-LIFE IN 87 PEDIATRIC-PATIENTS AFTER BMT - A STUDY OF THE GETMON
Authors: BADELL I IGUAL L GOMEZ P BUREO E CUBELLS J ORTEGA JJ MARTINEZ A MADERO L DANIEL M BAYES R
Citation: I. Badell et al., QUALITY-OF-LIFE IN 87 PEDIATRIC-PATIENTS AFTER BMT - A STUDY OF THE GETMON, Bone marrow transplantation, 21, 1998, pp. 761-761
GM-CSF IN ALLOGENIC BMT FOR ALL IN CHILDREN
Authors: MADERO L ORTEGA JJ MARTINEZ A BADELL I MUNOZ A GOMEZ P OLIVE T DIAZ MA
Citation: L. Madero et al., GM-CSF IN ALLOGENIC BMT FOR ALL IN CHILDREN, Bone marrow transplantation, 21, 1998, pp. 771-771
RESULTS OF INTENSIVE CHEMOTHERAPY IN CHILDREN WITH JUVENILE CHRONIC MYELOMONOCYTIC LEUKEMIA - A PILOT-STUDY
Authors: DEHEREDIA CD ORTEGA JJ COLL MT BASTIDA P OLIVE T
Citation: Cd. Deheredia et al., RESULTS OF INTENSIVE CHEMOTHERAPY IN CHILDREN WITH JUVENILE CHRONIC MYELOMONOCYTIC LEUKEMIA - A PILOT-STUDY, Medical and pediatric oncology, 31(6), 1998, pp. 516-520
INTENSIVE CHEMOTHERAPY (CHT), ALLOGENEIC (ALLO) OR AUTOLOGOUS (AUTO) HEMATOPOIETIC-CELLS TRANSPLANTATION (HCT) FOR HIGH-RISK ALL (HRALL) - RESULTS OF THE ONGOING PROTOCOL PETHEMA ALL-93
Authors: RIBERA JM ORTEGA JJ ORIOL A FONTANILLAS M MALDONADO J PARODY R RIVAS C HERNANDEZRIVAS JM DELPOTRO E BASTIDA P GONZALEZ ME CALVO C RODRIGUEZ JM FELIU E SANMIGUEL JF
Citation: Jm. Ribera et al., INTENSIVE CHEMOTHERAPY (CHT), ALLOGENEIC (ALLO) OR AUTOLOGOUS (AUTO) HEMATOPOIETIC-CELLS TRANSPLANTATION (HCT) FOR HIGH-RISK ALL (HRALL) - RESULTS OF THE ONGOING PROTOCOL PETHEMA ALL-93, British Journal of Haematology, 102(1), 1998, pp. 316-316
COMPARISON OF INTENSIVE CHEMOTHERAPY (CHT), ALLOGENEIC (ALLO) OR AUTOLOGOUS (AUTO) HEMATOPOIETIC-CELLS TRANSPLANTATION (HCT) FOR HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA (HRALL) - PRELIMINARY-RESULTS OF THE ONGOING PROTOCOL PETHEMA ALL-93
Authors: RIBERA JM ORTEGA JJ ORIOL A FONTANILLAS M MALDONADO J PARODY R RIVAS C HERNANDEZRIVAS JM DELPOTRO E TEROL MJ BASTIDA P GONZALEZVALENTIN ME FELIU E GARCIACONDE J DIAZMEDIAVILLA J SANMIGUEL JF
Citation: Jm. Ribera et al., COMPARISON OF INTENSIVE CHEMOTHERAPY (CHT), ALLOGENEIC (ALLO) OR AUTOLOGOUS (AUTO) HEMATOPOIETIC-CELLS TRANSPLANTATION (HCT) FOR HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA (HRALL) - PRELIMINARY-RESULTS OF THE ONGOING PROTOCOL PETHEMA ALL-93, Blood, 90(10), 1997, pp. 998-998
CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT) - A SURVEY OF THE INFECTIOUS-DISEASES WORKING PARTY OF EBMT
Authors: LINK H ARSENIEV L LJUNGMAN P ALESSANDRINO EP AMADORI S BANDINI G BEGUIN Y BRINCH L BRUNET S CHOPRA R CORDONNIER C DEWITTE T FAUSER A FERRANT AF GARCIACONDE J JULIUSSON G KUBEL M MANNA A MARTINEZRUBIO AM MUNDHENK P ORDEMANN R ORTEGA JJ POTTER M PRENTICE HP RAIMONDI R REMEZ K REUSSER P ROVIRA M RUSSELL J SELLESLAG D UDERZO C ZAUCHA JM
Citation: H. Link et al., CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT) - A SURVEY OF THE INFECTIOUS-DISEASES WORKING PARTY OF EBMT, Blood, 90(10), 1997, pp. 2424-2424
TEICOPLANIN PHARMACOKINETICS IN PEDIATRIC-PATIENTS
Authors: DUFORT G VENTURA C OLIVE T ORTEGA JJ
Citation: G. Dufort et al., TEICOPLANIN PHARMACOKINETICS IN PEDIATRIC-PATIENTS, The Pediatric infectious disease journal, 15(6), 1996, pp. 494-498
CHILDHOOD CALCINOSIS CUTIS
Authors: RODRIGUEZCANO L GARCIAPATOS V CREUS M BASTIDA P ORTEGA JJ CASTELLS A
Citation: L. Rodriguezcano et al., CHILDHOOD CALCINOSIS CUTIS, Pediatric dermatology, 13(2), 1996, pp. 114-117
FEASIBILITY AND RESULTS OF BONE-MARROW TRANSPLANTATION AFTER REMISSION INDUCTION AND INTENSIFICATION CHEMOTHERAPY IN DE-NOVO ACUTE MYELOID-LEUKEMIA
Authors: SIERRA J BRUNET S GRANENA A OLIVE T BUENO J RIBERA JM PETIT J BESSES C LLORENTE A GUARDIA R MACIA J ROVIRA M BADELL I VELA E DEHEREDIA CD VIVANCOS P CARRERAS E FELIU E MONTSERRAT E JULIA A CUBELLS J ROZMAN C DOMINGO A ORTEGA JJ
Citation: J. Sierra et al., FEASIBILITY AND RESULTS OF BONE-MARROW TRANSPLANTATION AFTER REMISSION INDUCTION AND INTENSIFICATION CHEMOTHERAPY IN DE-NOVO ACUTE MYELOID-LEUKEMIA, Journal of clinical oncology, 14(4), 1996, pp. 1353-1363
ALLOGENEIC AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN AML IN FIRSTREMISSION - THE SPANISH EXPERIENCE
Authors: ORTEGA JJ OLIVE T DEHEREDIA CD COLL MT BASTIDA P MASSUET L
Citation: Jj. Ortega et al., ALLOGENEIC AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN AML IN FIRSTREMISSION - THE SPANISH EXPERIENCE, Bone marrow transplantation, 18, 1996, pp. 53-58
T(5-12)(Q31-Q24) IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: TUSELL L CABALLIN MR COLL MD ORTEGA JJ BASTIDA P EGOZCUE J
Citation: L. Tusell et al., T(5-12)(Q31-Q24) IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, Cancer genetics and cytogenetics, 89(2), 1996, pp. 163-165
LATE REINDUCTION CHEMOTHERAPY HAS NO VALUE IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - RESULTS OF PETHEMA ALL-89 PROTOCOL
Authors: RIBERA JM ORTEGA JJ FONTANILLAS M ORIOL A
Citation: Jm. Ribera et al., LATE REINDUCTION CHEMOTHERAPY HAS NO VALUE IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - RESULTS OF PETHEMA ALL-89 PROTOCOL, Blood, 88(10), 1996, pp. 841-841
LOCALIZATION OF THE FANCONI-ANEMIA COMPLEMENTATION GROUP-A GENE TO CHROMOSOME 16Q24.3
Authors: PRONK JC GIBSON RA SAVOIA A WIJKER M MORGAN NV MELCHIONDA S FORD D TEMTAMY S ORTEGA JJ JANSEN S HAVENGA C COHN RJ DERAVEL TJ ROBERTS I WESTERVELD A EASTON DF JOENJE H MATHEW CG ARWERT F
Citation: Jc. Pronk et al., LOCALIZATION OF THE FANCONI-ANEMIA COMPLEMENTATION GROUP-A GENE TO CHROMOSOME 16Q24.3, Nature genetics, 11(3), 1995, pp. 338-340
PRESENTATION OF A PCR-NUCLEASE PROTECTION STRATEGY FOR MINIMAL RESIDUAL DISEASE MONITORING IN B-ALL
Authors: LIMON A BERTRAN J LLUCIA M CARMONA M CANALS C ORTEGA JJ GARCIA J RUEDA F
Citation: A. Limon et al., PRESENTATION OF A PCR-NUCLEASE PROTECTION STRATEGY FOR MINIMAL RESIDUAL DISEASE MONITORING IN B-ALL, Leukemia, 9(4), 1995, pp. 656-661
Risultati: 1-25 | 26-30